Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

Phase 4
3(30.0%)
N/A
3(30.0%)
Phase 1
2(20.0%)
Phase 2
1(10.0%)
Phase 3
1(10.0%)
10Total
Phase 4(3)
N/A(3)
Phase 1(2)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT07141251Phase 1Recruiting

Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)

Role: collaborator

NCT06783933Active Not Recruiting

Artificial Intelligence-assisted Diagnosis

Role: collaborator

NCT04694495Completed

HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

Role: collaborator

NCT02342145Phase 4Completed

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Role: collaborator

NCT06013618Phase 2Recruiting

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Role: collaborator

NCT06824376Not ApplicableRecruiting

Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)

Role: collaborator

NCT05328531Phase 1Completed

Clinical Study of Genakumab for Injection in Patients With Acute Gout

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT06742450Not ApplicableRecruiting

Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease

Role: collaborator

NCT05937178Recruiting

Real-world Study Optimizing Nucleotide-analogues

Role: collaborator

NCT05263219Phase 3Recruiting

DEB-TACE+HAIC vs. HAIC for Large HCC

Role: collaborator

NCT03938311Not ApplicableUnknown

Time Window for Ischemic Stroke First Mobilization Effectiveness

Role: collaborator

NCT04677439Phase 4Unknown

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Role: collaborator

NCT03108794Unknown

A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B

Role: collaborator

All 14 trials loaded